Brought to you by 
Boston Scientific buys CryoCor for about $17.2mm in cash
Apr 2008
Executive Summary
After working together on cryoablation treatments for cardiac arrhythmia over the last year, Boston Scientific has announced it will buy CryoCor (minimally invasive cardio devices) for a total of about $17.2mm ($1.35 in cash for each share, a slight discount).
Deal Industry
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Includes Contract
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific buys CryoCor for about $17.2mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice